Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 11/20 | 0.48 |
| ▸ | F2 | P00734 | 3/20 | 0.44 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.43 |
| ▸ | CPA1 | P15085 | 1/20 | 0.42 |
| ▸ | CPA2 | P48052 | 1/20 | 0.42 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13938202 | 0.90 | FKBP1A (0.46) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL1978322 | 0.85 | FKBP1A (0.47) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL13938196 | 0.82 | FKBP1A (0.49) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL1980094 | 0.82 | GHSR (0.45) | CTSLCTSK | |
| SCHEMBL13938181 | 0.82 | ALDH1A1 (0.48) | — | |
| SCHEMBL1979768 | 0.79 | FKBP1A (0.52) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL13938201 | 0.79 | FKBP1A (0.48) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL1979169 | 0.78 | FKBP1A (0.55) | FKBP1AF2PIN1CTSLCTSK | |
| SCHEMBL13938099 | 0.74 | ABCB1 (0.49) | — | |
| SCHEMBL1980404 | 0.73 | HSD17B10 (0.53) | FKBP1AF2PIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7476680-B2 | Substituted heterocyclic compounds for treating multidrug resistance | H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) | 2009-01-13 | — | — | US | disclosed |
| US-7476680-B2 | Substituted heterocyclic compounds for treating multidrug resistance | H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) | 2009-01-13 | — | — | US | disclosed |
| EP-1326833-A2 | SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR TREATING MULTIDRUG RESISTANCE | THE PROCTER & GAMBLE COMPANY (US) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002032869-A2 | SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR TREATING MULTIDRUG RESISTANCE | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-25 | — | — | WO | disclosed |